The hardware bottleneck
Everyone is competing for the same short list of qualified solvents, sorbents, cell chemistries, and EPCs. FEED cycles tie up your engineers for 12–18 months before a single tonne is captured.
Naru sources, qualifies, funds, and lands biotech and clean-energy innovation across borders. One bilingual desk — from first brief to signed deal.
Canada has the funding and the storage. Korea has the technology. Nobody is running the bridge.
We work alongside
Canada's clean-economy funding stack is one of the most generous in the world. The bottleneck isn't capital — it's everything between a funded mandate and a working technology.
Everyone is competing for the same short list of qualified solvents, sorbents, cell chemistries, and EPCs. FEED cycles tie up your engineers for 12–18 months before a single tonne is captured.
A pilot that works in the lab stalls on the climb to 10 MW slipstream and 100 MW commercial. The know-how to bridge that gap sits in a very small global pool.
You scan US suppliers reflexively. Korean R&D — including capture pilots that have run at 10 MW since 2010 — is functionally invisible in English-language deal flow.
We map your technical brief onto Korean GRIs, university TLOs, and scale-ups — and hand you a scored shortlist.
NRC IRAP, SIF, Net Zero Accelerator, the NRC × KIAT co-innovation call — sequenced and stacked.
Licensing, technical-services agreements, JV structures, clinical and utility pilots — matched and brokered.
Korean strategics and CVCs for your raise; Canadian capital for inbound Korean ventures. Both directions.
Curated Korea–Canada roundtables and delegations — the relationship flywheel that makes deals possible.
Every cross-border deal needs three roles: the analyst who vets the science, the dealmaker who builds trust and closes, and the operator who runs it after signing. Our team specializes in the dealmaking — and we partner with a named bench of technical advisors and operating firms for the rest, so every step is led by someone who does that work full-time.
Why this mattersWe don't do everything-and-also-Korea. Two domains, chosen because the deals are high-value, the cycles favour a patient agent, and the public funding is abundant on both sides.
KRIBB, KAIST, SNU and the K-bio cluster pair with Canadian hospital networks and clinical infrastructure. Antibody platforms, regenerative therapies, cardiometabolic devices.
KIER and KIST hold capture chemistries with 10 MW pilot data. Canadian battery JVs and CCUS operators are deploying multi-billion-dollar capex right now.
Korea R&D intensity
2nd in the OECD. Canada sits near 1.7%.
Canada Growth Fund
Concessional capital for clean-economy deployment.
CCUS ITC (capture)
Refundable. 37.5% on transport & storage.
Project envelope covered
By stacking Canadian + Korean public capital.
Biotech and clean energy are capital-heavy and policy-timed. Korea is not a generic “Asia option”: it is a concentrated R&D and industrial deployment stack with a formal trade and innovation spine to Canada. The points below are drawn from public frameworks — the same ones we map in The K-Tech Carbon Bridge guide.
While Canada excels in early-stage R&D (TRL 1–4), scaling up to commercial facilities (TRL 5–9) can be a major bottleneck. South Korea is arguably the world’s best at Lab-to-Fab commercialization — with the world-class EPC and manufacturing ecosystem required to turn lab-scale innovation into commercial-scale reality, faster than anyone else.
In today’s geopolitical climate, navigating the supply chain between the US and China is risky. South Korea offers the perfect friend-shoring destination — top-tier technology and strict IP protection laws, with a stable and reliable partnership without the geopolitical risks or aggressive takeover threats.
In North America, project development and engineering cycles can be slow — which directly increases your CAPEX. South Korea’s engineering culture is built on unprecedented agility and speed. Partnering with a Korean firm can cut pilot design and procurement time in half, saving millions in CAPEX.
Partnering with a Korean company doesn’t just bring technology — it brings capital. The Korean government is deploying billions into global R&D for carbon neutrality. With the right partnership structure, we can match Canadian grants (SDTC, IRAP) with Korean government funds — drastically lowering the equity burden and risk for your project.
Canada’s refundable CCUS Investment Tax Credit applies to eligible expenditures from 2022 through 2030 at the headline rates (including up to 50% on eligible capture equipment and 37.5% on transport, storage, and use). From 2031 to 2040, those rates are halved — then the credit ends. Capital scheduled after 2030 still matters, but the envelope is strictly smaller.
Source: Canada Revenue Agency — CCUS Investment Tax Credit (clean-economy ITC rules).
Ottawa’s emissions-reduction plan points to at least ~15 Mt CO₂/yr of permanent storage capacity by 2030 — roughly tripling today’s installed base. Korea’s national framework includes a ~11.2 Mt CO₂/yr CCUS sequestration target for 2030. Both governments are mobilizing capital into the same decade — which means EPC slots, offtake, and qualified vendors lock up early, not at FEED completion.
Sources: Natural Resources Canada — Carbon Management Strategy; Republic of Korea 1st Basic Plan (2023).
Korea’s Act on the Capture, Transportation, Storage and Utilization of Carbon Dioxide entered into force in February 2025, clarifying licensing, infrastructure, and market rules for CO₂ as a managed resource. That reduces ambiguity for Korean champions — and signals a busier outbound technology and equipment lane as projects firm up. Waiting until “everyone sources Korea” means higher licence fees and picked-over pilot windows.
Source: National Assembly enactment / legal commentary (e.g. Kim & Chang, 2024–2025).
The 2023 MOU between Canada and Korea on critical minerals, clean-energy transition, and energy security explicitly names cooperation on CCUS and carbon removal. The July 2024 Canada–Korea Comprehensive Strategic Partnership action plan adds implementation rails for trade, supply chains, and innovation. Programs and ministerial trade missions are aligned with that direction — the practical work is matchmaking and diligence, not writing white papers.
Non-dilutive pathways shift: for example, SDTC was wound down as an independent foundation in mid‑2024 with programming folded toward NRC‑led successors — a reminder to sequence grants with current owners, not last year’s deck. The NRC IRAP × KIAT call is annual; CCUS ITC eligibility ties to project design choices made before procurement.
Source: Government of Canada announcements; NRC / IRAP program pages.
We are not immigration counsel, tax counsel, or EPC. We route you to primary sources and named counterparties, then run the agent function until close.
Book a Discovery CallA 10-page field guide most of your competitors haven't read: the Korean CCUS and biotech ecosystem you can't easily Google in English, and a working map of how to stack Canadian + Korean public capital on the same project.
No spam. One follow-up email, then we leave you alone.
Please enter a valid work email address.
Something went wrong. Please try again in a moment.
The PDF opens in a new tab. One follow-up email may follow — unsubscribe anytime.
A Canadian operator's guide to Korean innovation, technology, and cross-border capital.
Twenty minutes. We'll clarify your brief, name the Korean archetypes that fit, and map your funding sequence. NDA first if you prefer.
Most Canadian clients buy one or two lines as a package. Prices are bands, shown up front — transparency is a qualifier.
We map your technical brief onto KIPRIS, NTB, and the named portfolios of KIER, KIST, KEPCO E&C, KIGAM, KRIBB, KAIST and tier-1 university TLOs. You receive a scored shortlist of 3–5 candidates with redacted technical summaries.
The highest-leverage line. We identify and sequence the Canadian public funding your project qualifies for — NRC IRAP, SIF, Net Zero Accelerator, the NRC × KIAT co-innovation call — and structure the Korean-side match.
Exclusive licences, technical-services agreements, JV structures, clinical partners, utility pilots, university TLO connections — sourced, qualified, and brokered through signing.
Korean strategics and CVCs for Canadian companies raising; Canadian capital and family offices for inbound Korean ventures. Bilingual pitch refinement and roadshow logistics included.
Curated Korea–Canada roundtables, an annual delegation, and senior-executive dinners. The relationship flywheel that turns cold sourcing into warm deals.
That's what the Discovery Call is for. We'll tell you which one or two services actually move your project — and which you don't need.
No black boxes. Every stage has a named owner, a deliverable, and a gate you control.
We extract the job your technology must do, then map it onto the Korean portfolios that fit.
Deliverable: scored shortlist of 3–5
Bilingual diligence with our advisor bench: patent strength, FTO, TRL, export controls, KR-government strings.
Deliverable: qualified pipeline
Term-sheet drafting in KR + EN. In parallel: the NRC × KIAT call, ITC eligibility, SIF pathway.
Deliverable: term sheet + funding stack
Bilingual execution, escrow logistics, then milestone tracking and royalty audits post-close.
Deliverable: signed deal + stewardship
Fixed fee, 4–6 weeks. Filters tire-kickers and pays for our diligence time.
Ongoing sourcing, qualification, and introduction logistics. 3–6 months.
10 / 8 / 6 / 4 / 2% per tranche of deal value. Paid only on a closed deal.
Of non-dilutive capital secured, payable on disbursement.
No — and neither do we, in the way you might think. Technical review is delivered by a named advisor bench. Our job is to route the science to the right reviewer and run the deal. We explain exactly who does what before you sign anything.
On total transaction value — upfront plus milestones, with royalties capped. Lehman scale: 10/8/6/4/2% per tranche. It's the industry-standard structure, not something we invented.
Yes — that's the core of the model. Your Korean partner can claim KIAT international R&D funding while you claim NRC IRAP, the CCUS ITC, and a SIF or Net Zero Accelerator top-up. Stacked, public capital can cover well over half the project envelope.
No success fee on a failed close — the retainer covers work to date. We'll substitute an alternative candidate from the shortlist and keep going.
The US is crowded and you're already searching there. Korea has world-benchmark R&D, a trade backbone with Canada (CKFTA), a 2024 industrial-cooperation MOU, and institutions actively seeking international demonstration sites. It's the highest-value sourcing pool nobody in your peer group is working.
High-value deals, long cycles that favour a patient agent, and abundant public funding on both sides. Pick your sector.
Korean cell makers, cathode producers, and government research institutes hold the global benchmark in EV battery materials, hydrogen systems, and CO₂ capture chemistry. Canadian battery JVs and CCUS operators are deploying multi-billion-dollar capex right now — and competing for the same scarce supply chain.
KIER · KIST · KEPCO E&C · KIGAM · UNIST · KIST quantum/materials groups
CCUS operators · battery JV operators · hydrogen utilities · advanced-manufacturing SMEs
Exclusive licence (Canada territory) · technical-services + option · JV with a cell or cathode maker
CCUS ITC · NRC IRAP × KIAT · Net Zero Accelerator · SIF · provincial top-ups
The K-Tech Carbon Bridge — our 10-page field guide for Canadian CCUS operators.
Specificity is the whole point. Named institutions, named programs, named bilateral instruments. This is the page that proves we're not bluffing.
Industrial policy, patent registry, the search backbone.
National Tech-Bank marketplace + bilateral matching programs.
The actual technology source — capture chemistry to biologics.
Samsung, LG, SK, POSCO open-innovation arms; Kim & Chang, Lee & Ko.
Advisory, deployment capital, and the clean-economy ITC stack.
Regional top-ups, sector funds, and pilot-site support.
Partner offices for joint development and inbound technology.
Government-to-government rails into the Korean market.
The 2024 Canada–Korea Comprehensive Strategic Partnership, the NRC × KIAT co-innovation call (annual since 2020), and CKFTA — the trade backbone in force since 2015.
We believe great Korean research deserves great commercialization in Canada — and Canadian industry deserves a real door into it.
You don't need a PhD to close a cross-border deal — you need domain literacy and a deal-maker's instincts. The agent opens doors, builds trust, and negotiates. The technical review is delivered by a named advisor bench. Trying to be the analyst and the agent is how deals stall. We chose a lane, and we're honest about it.
Analysts, counsel, and program leads — bilingual KR/EN preferred.
Field-tested pieces we wish we'd had when we started.
A 10-page guide to the Korean CCUS ecosystem and the Canadian + Korean funding stack — written for operators, sourced throughout.
Please enter a valid work email address.
Something went wrong. Please try again in a moment.
The PDF opens in a new tab after you submit your email.
A Canadian operator's guide to Korean innovation & cross-border capital.
We reply within one business day. Choose the best-fitting intent below.
We reply within one business day.